Application no. and date | 18182274.3 (espacenet) (Federated) (European Patent Register), 20131210 | Patent/reg. no. and date | DK/EP 3495380, 20220330 | Publication date | 20190612 | Priority no. and date | US 201261735823 P, 20121211 | EP pub. no. and date |
EP 3495380 20190612 | Effective date | | Applicant/owner | MedImmune Limited, Milstein Building Granta Park
Cambridge Cambridgeshire CB21 6GH, GB | Applicant ref. no. | 1635199 | Inventor | BEDNAREK, Maria, A, MedImmune Limited Milstein Building, Granta Park
Cambridge, Cambridgeshire CB21 6GH, GB, AGORAM, Balaji, Milstein Building Granta Park
Cambridge, CB21 6GH, GB, BURMEISTER, Nicole, Milstein Building Granta Park
Cambridge, CB21 6GH, GB, BENTHEM, Lambertus, c/o AstraZeneca AB
SE-151 85 Södertälje, SE, FAIRMAN, David, Milstein Building Granta Park
Cambridge, CB21 6GH, GB, FRITSCH-FREDIN, Maria, c/o AstraZeneca AB
SE-151 85 Södertälje, SE, JACKSON, Ronald Henry, Milstein Building Granta Park
Cambridge, CB21 6GH, GB, LOFMARK, Rasmus Jansson, c/o AstraZeneca AB
SE-151 85 Södertälje, SE, METCALFE, Jaqueline, Milstein Building Granta Park
Cambridge, CB21 6GH, GB, ANTONSSON, Madeleine, c/o AstraZeneca AB
SE-151 85 Södertälje, SE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 38/00 (2006.01) | Title | GLUCAGON/GLP-1-COAGONISTER TIL BEHANDLING AF OBESITAS | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|